Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Serina Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $2.03K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$2.03K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Serina Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Simon Farrell | Director | – | Jul 23, 2026 | 1 |
| Brannan Stephen K. | Director | 1,000 | Jul 9, 2026 | 3 |
| Wilson Karen J | Director | 10,100 | Jun 22, 2026 | 4 |
| Bailey Gregory | Director | 8,564,382 | Jun 22, 2026 | 3 |
| Venkatesan Jay | Director | 231,705Indirect | Jun 22, 2026 | 3 |
| Marshall Richard Peter | Director | 12,183 | Jun 22, 2026 | 3 |
| Ledger Steven A | Chief Executive Officer | 10,100 | May 27, 2026 | 3 |
| Curhan Gregory S | Chief Financial Officer | – | May 26, 2026 | 1 |
| Moreadith Randall | Chief Scientific Officer | 0 | May 26, 2026 | 27 |
| Tenjarla Srini | SVP, CMC & Formulation | – | May 26, 2026 | 2 |
| Gill Simba | Director | – | Feb 17, 2026 | 1 |
| Juvenescence Ltd | 10% Owner | 3,267,188Indirect | Feb 3, 2025 | 0 |
| Mintz Steven | Director | 17,443Indirect | Sep 16, 2024 | 0 |
| Harris J Milton | Director | – | Apr 3, 2024 | 0 |
| Gross Remy | Director | – | Apr 3, 2024 | 0 |
| West Michael D | Chief Executive Officer | 41,982 | Mar 14, 2023 | 0 |
| Hackett Joanne M. | Director | – | Feb 4, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 31, 2024 (view filing) | May 29-30 | 2 days | Bailey GregoryDirector | PPurchase | +6.38K | $9.50 | +$60.6K | +46.1%20.2K after | 2 lots |
| May 29, 2024 (view filing) | May 28 | 1 day | Bailey GregoryDirector | PPurchase | +9.02K | $9.50 | +$85.7K | +187.5%13.8K after | |
| May 24, 2024 (view filing) | May 21-23 | 3 daysLate | Bailey GregoryDirector | PPurchase | +3.29K | $9.50 | +$31.2K | +216.0%4.81K after | 2 lots |
| May 23, 2024 (view filing) | May 17-21 | 6 daysLate | Mintz StevenDirector | PPurchase | +12.4K | $9.76 | +$120.8K | New position1.24K after | 6 lots |
| May 23, 2024 (view filing) | May 21 | 2 days | Bailey GregoryDirector | PPurchase | +1.42K | $9.50 | +$13.5K | +1,422.0%1.52K after | |
| May 22, 2024 (view filing) | May 20 | 2 days | Bailey GregoryDirector | PPurchase | +100 | $9.00 | +$900 | New position100 after | |
| Feb 14, 2022 (view filing) | Feb 3 | 11 daysLate | Juvenescence Ltd10% Owner | PPurchase | +308.6K | $0.00 | $0 | –308.6K after | Derivative |